Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysis

21 Jun 2023

Abstract excerpt

To evaluate the changes in the gut microbiota associated with changes in the biochemical markers of nonalcoholic fatty liver disease (NAFLD) after a lifestyle intervention with the Mediterranean diet. Participants (n = 297) from two centers of PREDIMED-Plus trial (Prevención con Dieta Mediterránea) were divided into three different groups based on the change tertile in the Hepatic Steatosis Index (HSI) or the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gut microbiota and health
Share to Liver Disease Diagnosis and Treatment
Share to Nutrition and Health in Aging

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37345236
DOI: 10.1080/19490976.2023.2223339

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysisPMID 37345236Read ↗

Phenotyping non-alcoholic fatty liver disease by the gut microbiota: Ready for prime time?Semantic proximity Read ↗

Gut Microbiota Patterns in Patients with Non-Alcoholic Fatty Liver Disease: A Comprehensive Assessment Using Three Analysis MethodsSemantic proximity Read ↗

Fatty Liver Disease and Gut Microbiota: A Comprehensive UpdateSemantic proximity Read ↗

Gut Microbiota Profile Changes in Patients with Inflammatory Bowel Disease and Non-Alcoholic Fatty Liver Disease: A Metagenomic StudySemantic proximity Read ↗

Correlation of gut Firmicutes/Bacteroidetes ratio with fibrosis and steatosis stratified by body mass index in patients with non-alcoholic fatty liver diseaseSemantic proximity Read ↗

The role of microbiota in nonalcoholic fatty liver disease: mechanism of action and treatment strategySemantic proximity Read ↗

Altered Fecal Microbiota Correlates with Liver Biochemistry in Nonobese Patients with Non-alcoholic Fatty Liver DiseaseSemantic proximity Read ↗

NAFLD/MASLD and the Gut–Liver Axis: From Pathogenesis to Treatment OptionsSemantic proximity Read ↗

Characteristics of fecal microbiota in non-alcoholic fatty liver disease patientsSemantic proximity Read ↗

Gut microbiota and non-alcoholic fatty liver diseaseSemantic proximity Read ↗

Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapiesSemantic proximity Read ↗

Gut microbiota dysbiosis in patients with non-alcoholic fatty liver diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.